» Authors » Adriana Camargo Ferrasi

Adriana Camargo Ferrasi

Explore the profile of Adriana Camargo Ferrasi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 103
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rabenhorst S, Ferrasi A, Barboza M, Melo V
Sci Rep . 2024 Nov; 14(1):28890. PMID: 39572621
Helicobacter pylori infection is a major risk factor for gastric adenocarcinomas. In the case of the intestinal subtype, chronic gastritis and intestinal metaplasia are well-known sequential steps in carcinogenesis. H....
2.
Abrahim N, Cavalcante R, Pardini M, Rabenhorst S, Ferrasi A
Eur J Cancer Prev . 2024 Oct; PMID: 39480819
Oral cancer is a public health problem worldwide. Late diagnosis results in a low survival rate. However, this tumor can arise from oral precancerous lesions and identification of biomarkers in...
3.
Ferrasi A, Lima S, Galvani A, Delafiori J, Dias-Audibert F, Catharino R, et al.
World J Hepatol . 2023 Dec; 15(11):1237-1249. PMID: 38075010
Background: Chronic Hepatitis C (CHC) affects 71 million people globally and leads to liver issues such as fibrosis, cirrhosis, cancer, and death. A better understanding and prognosis of liver involvement...
4.
Botta F, Rocha L, de Souza V, Dos Reis P, Lima E, Ferrasi A, et al.
Neurosurg Rev . 2023 Jul; 46(1):184. PMID: 37493965
Brain metastases (BM) from lung cancer are among the most common intracranial tumors. Several studies have published scales to estimate the survival of patients with BM. Routine access to molecular...
5.
Medolago N, Ferrasi A, da Rocha O, de Moura Campos Pardini M, Grotto R, Silva G
Curr Rheumatol Rev . 2022 Jun; 19(1):58-63. PMID: 35733307
Background/aims: Hepatitis C has been associated with rheumatologic manifestations (HCV-related RM). Clinically, HCV-related RM may be indistinguishable from the symptoms that occur in diffuse connective tissue diseases (DCTD-related RM), making...
6.
Ferrasi A, Fernandez G, Grotto R, Silva G, Goncalves J, Costa M, et al.
Sci Rep . 2020 Jun; 10(1):9886. PMID: 32555359
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death in the world, and about 80% of the cases are associated with hepatitis B or C. Genetic and epigenetic...
7.
Medolago N, Ferrasi A, da Rocha O, de Moura Campos Pardini M, Grotto R, Galvani A, et al.
Rev Soc Bras Med Trop . 2020 Jan; 53:e20190210. PMID: 31994660
Introduction: Hepatitis C virus (HCV) infection is involved in the pathogenesis of autoimmune and rheumatic disorders. Although the human platelet antigens (HPA) polymorphism are associated with HCV persistence, they have...
8.
Lima E, Ferrasi A, Kaasi A
Arq Bras Cardiol . 2019 Aug; 113(1):18-19. PMID: 31411289
No abstract available.
9.
Hebeler-Barbosa F, Massolini V, Watanabe T, Silva G, Barbosa A, Simoes R, et al.
Medicine (Baltimore) . 2019 Jul; 98(29):e16376. PMID: 31335686
The HIV subtype B is the most frequent in Brazil. The HIV subtype B' codes the amino acids glicine-tryptophan-glicine (GWG) instead of glicine-proline-glicine on the tip of gp120 V3 loop....
10.
Grotto R, Santos F, Picelli N, Silva G, Ferrasi A, Rodrigues Sarnighausen V, et al.
Rev Soc Bras Med Trop . 2019 Jul; 52:e20170427. PMID: 31271612
Introduction: HPA polymorphism has been associated with HCV presence and fibrosis progression in chronic hepatitis C. However, it is unknown if there is an association between HPA-1 polymorphism and hepatocellular...